https://www.accesswire.com/540709/ReShape-Lifesciences-Announces-Fourth-Quarter-and-Full-Year-2018-Financial-Results

SAN CLEMENTE, CA / ACCESSWIRE / April 1, 2019 / ReShape Lifesciences Inc. (NASDAQ: RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today reported financial results for the three months and year ended December 31, 2018.

Recent Highlights and Accomplishments